Evidence map›Paper›PMID 19114554›Full record

ArticleMolecular and cellular biology2009

TFIIB recognition elements control the TFIIA-NC2 axis in transcriptional regulation.

Wensheng Deng, Barbora Malecová, Thomas Oelgeschläger, Stefan G E Roberts

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cytoskeletal protein filamin A is a nucleolar protein that suppresses ribosomal RNA gene transcription.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Wensheng DengFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Barbora Malecová
Thomas Oelgeschläger
Stefan G E Roberts
Marie Curie · GBUniversity of Manchester · GB

Funding

Wellcome TrustWellcome Trust 061207/Z/00/Z/CH/TG/dr
6 · The paper itself

Abstract

TFIIB recognizes DNA sequence-specific motifs that can flank the TATA elements of the promoters of protein-encoding genes. The TFIIB recognition elements (BRE(u) and BRE(d)) can have positive or negative effects on transcription in a promoter context-dependent manner. Here we show that the BREs direct the selective recruitment of TFIIA and NC2 to the promoter. We find that TFIIA preferentially associates with BRE-containing promoters while NC2 is recruited to promoters that lack consensus BREs. The functional relevance of the BRE-dependent recruitment of TFIIA and NC2 was determined by small interfering RNA-mediated knockdown of TFIIA and NC2, both of which elicited BRE-dependent effects on transcription. Our results confirm the established functional reciprocity of TFIIA and NC2. However, our findings show that TFIIA assembly at BRE-containing promoters results in reduced transcriptional activity, while NC2 acts as a positive factor at promoters that lack functional BREs. Taken together, our results provide a basis for the selective recruitment of TFIIA and NC2 to the promoter and give new insights into the functional relationship between core promoter elements and general transcription factor activity.

Indexed as

Cell LineHumansPhosphoproteinsPromoter Regions, GeneticTranscription FactorsTranscription Factor TFIIATranscription Factor TFIIBTranscription, Geneticdown-regulator of transcription 1PhosphoproteinsTranscription FactorsTranscription Factor TFIIATranscription Factor TFIIB

Identifiers

PMID19114554
PMCPMC2648230
OpenAlexW2096233789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.